The company, which helps health systems operate virtual care programs through its platform, will use the new funds to scale its go-to-market efforts, invest in the development of new capabilities and hire new employees.
Tia, a concierge clinic combining primary care and OBGYN services, recently raised $100 million in funding. Amid a surge of financing into women’s health startups, CEO Carolyn Witte said investors’ perspectives are changing.
The maternal care startup is backed by major health systems including MemorialCare Health System, whose innovation arm led the most recent funding round. Babyscripts offers a mobile app providing education and resources for the pregnancy and postpartum journey.
The company, which partners with health systems and schools to provide virtual therapy services for kids, will use the Series A funds to expand. The round was led by New Capital Partners, with participation from LRVHealth and OSF Ventures.
NHS England will get an extra £5.4 billion ($7.5 billion) in funding over the next six months to respond to COVID-19 and address a backlog in care caused by the pandemic, according to the UK government. The total includes £1 billion to get delivery of routine surgeries and treatments to patients delayed by COVID-19 back …
The company offers clinical triage via an artificial intelligence-powered chatbot and unlimited virtual visits through a majority of its plans. Inspired by the Israeli healthcare system, patients on Antidote plans pay a monthly membership fee.
The company, which provides telemedicine and digital programs focused on maternal health, will use the funds raised to expand its services to new populations, including international patients and Medicaid members.
In an interview with PharmaShots, Konstantin Mehl, President, CEO, and Founder at Kaia Health shared his views on the grant of $75M Series C funding to expand clinical capabilities & transform the treatment path for musculoskeletal (MSK) and chronic obstructive pulmonary disease (COPD) care in the US and EU. Shots: The funding will extend the …
Reify, which makes software for clinical trial recruitment and decentralized clinical trials, raised $220 million in a funding round led by Coatue Management.
The company offers a remote patient monitoring platform that enables clinicians to not only monitor patients at home but also provide personalized feedback via texts and video visits. The platform will be deployed at LifePoint Health facilities and used to deliver remote care to more than 100,000 patients.
In the second quarter of 2021, the top five deals alone were worth $1.6 billion, representing 30% of the total funding raised. In addition, six telehealth companies joined the unicorn club, including LetsGetChecked and Thirty Madison.
The Patient-Centered Outcomes Research Institute has awarded the funds to studies that span a range of healthcare issues, including maternal care, suicide prevention and clinical effectiveness research in arenas like telemedicine and diabetes.
The company’s data processing platform can help payers comply with the law banning surprise billing, which requires insurers to process all provider directory updates in less than two days starting in 2022.
With a goal of making precision medicine the standard of care at health systems, Sema4 struck a nearly $800 million deal with CM Life Sciences to go public. The company, which offers tools that combine genomic and clinical data to glean patient care insights, will get $500 million in cash proceeds to grow its business.
After more than doubling its patient volumes during the pandemic, Carbon Health raised funding to further its growth plans. The company said it plans to open 1,500 clinics by 2025.
Led by Kaiser Permanente, the Series D financing round will enable OM1 to expand its data networks into chronic disease areas, including rheumatology and behavioral health, and advance its AI analytics models.
Launched by 14 health systems in February, the data analytics company building a repository of de-identified data will use the funds to develop its platform that aims to support clinical decision making and drug development.
Digital health funding broke records again as companies raised a total of $14.7 billion in the first half of the year. Several companies also went public, but those that have gone public since 2020 have recently underperformed the NASDAQ.
Tendo Systems, a company that is co-developing a digital engagement platform with provider organizations like Jefferson Health, raised $50 million in a new funding round. The funds will be used to advance the development of the platform, which aims to be the “OpenTable” of healthcare.
The INVEST Precision Medicine conference cast a spotlight on the role of children’s hospitals, biopharma companies, diagnostic companies and startups in biopharma innovation. The video recordings of the conference sessions are now available to view.
The Biden Administration has said it will allocate $3 billion of its pandemic rescue plan to the development of a new generation of antiviral therapies for COVID-19, as well as future viral threats. The plan was announced today by National Institute of Allergy and Infectious Diseases (NIAID) director and chief medical advisor Anthony Fauci, who …
Panelists at MedCity INVEST Precision Medicine said startups can gain valuable expertise and experience through the process of seeking out non-dilutive funding.
AllyAlign Health, which offers health plans for seniors like Medicare Advantage and institutional special needs plans, has raised $300 million in funding. It will use the funds to scale its business.
The startup, which currently has four direct-to-consumer brands, recently passed a $1 billion valuation. It plans to use the funds to market its services to a new customer: health plans.
HHS is partnering with nonprofit Global Health Investment Corporation to launch a health security fund. The fund will be used to invest in technologies that can help prevent or respond to public health emergencies, like future pandemics.
Cynerio, a provider of cybersecurity and asset management solutions, raised $30 million in a Series B funding round. The company will use the capital to expand operations globally and grow sales and marketing efforts.
DrFirst, which provides an array of services including telehealth and e-prescribing, received a $50 million equity investment from Sixth Street Growth. The company plans to use the funds to expand its offerings and further connect healthcare stakeholders.
According to a survey conducted by Catalyst @ Health 2.0, a whopping 41% of digital health companies said their revenue was above expectations last year. Despite reporting longer sales cycles, most companies still were optimistic about their business prospects going into 2021.
Capsule, an online pharmacy startup that offers same-day prescription delivery, raised $300 million in funding. It plans to use the funds to build out an online marketplace for digital health solutions.
Virta Health, a digital health startup with an app-based coaching program for type 2 diabetes, raised $133 million led by Tiger Global. Unlike other digital health companies, Virta builds its program around a ketogenic diet.
The company is planning to use the newly raised funds to scale its remote patient monitoring solution, which integrates data from wearables and patient-reported symptoms to give clinicians a virtual view into patients’ health at home. The company’s plans also include doubling its workforce this year.
Healthcare companies had another record-breaking quarter, according to CBInsights. They raised a total of $31.6 billion in the first quarter, including big investments in telehealth and health IT.
The health insurance technology company has raised $15 million in a Series A funding round. It will use the funds to expand access to its supplemental health plan nationwide and engage in new partnerships.
Volastra Therapeutics is developing drugs for cancer metastasis, the cause of the vast majority of cancer deaths. The startup has $44 million in funding and an R&D partnership with Microsoft to develop new digital tools to detect and predict metastasis.
Digital health startups raised a record-breaking $6.7 billion in the first quarter of 2021. Large funding rounds propelled them past previous months.
With the focus on COVID-19 over the last year it’s easy to forget another deadly pandemic caused by antimicrobial resistance (AMR), which could lead to the most innocuous of infections becoming life threatening. The Novo Holding REPAIR Impact Fund is hoping to change this with its latest call for investment proposals to fight AMR. While …
Advocate Aurora Health has launched a subsidiary focused on making investments in companies that enhance health and wellbeing. The subsidiary has already made its first move, leading a $25 million funding round for a telenutrition provider.
Ro, a direct-to-consumer health startup, recently raised a $500 million funding round. It plans to use the funds to expand into at-home diagnostics and care.
A new digital health company — spun out from Providence’s Digital Innovation Group — has raised $20 million in its first funding round. The company offers a platform that aims to help providers coordinate and manage digital care services.
The healthcare analytics company will use the funds, raised in a Series C financing round, to scale its cloud-based platform that offers providers, payers and pharma companies insights to inform business decision-making.
Cedar, a healthcare finance technology company, saw its valuation jump to $3.2 billion after raising $200 million in a Series D funding round. It plans to use the new funds to expand patient touchpoints and build out new use cases.
The health technology company’s valuation skyrocketed to $1.3 billion following its latest funding round. It plans to use the new funds to launch Innovaccer Health Cloud, which will aggregate and normalize data from different systems and support the development of interoperable apps.
The company partners with independent practices, health centers and clinics to establish primary care-focused accountable care organizations.
States will get some much needed support to roll out a coronavirus vaccine. Last week, the Department of Health and Human Services shared it would roll out $22 billion in funding to support state testing and vaccination efforts.
DNA testing company 23andMe raised $82.5 million in funding, according to a recent filing. Earlier this year, decreased sales of tests kits led to cuts at the company and its competitors.
With the new funds, the health data optimization and interoperability company will invest in product development. The latest funding round was led by Centene Corp.
The health technology company raised a whopping $130 million in a Series D funding round. Its solutions aim to improve operational efficiency and better manage patient volume through predictive analytics, a growing need for providers as Covid-19 cases rise.
Denmark’s MinervaX has raised €47.4 million (around $56 million) in a Series B funding round to take its novel group B streptococcus (GBS) vaccine into mid-stage clinical trials. When and if the pandemic finally recedes there will still be an ongoing issue with a dearth of new antibiotics and a growing number of bacterial strains …
The technology provider for independent primary care practices plans to use the new funds to further invest in its core platform and add new solutions, such as billing and patient collections capabilities.
SoftBank’s second Vision Fund led the recent funding round. Pear plans to use it to accelerate reimbursement coverage for its three FDA-cleared products.
The Austin-based startup has distributed more than 500,000 Covid-19 test kits to date, and expects total sales to quadruple by the end of the year.
China’s Sinovac has raised $515 million to increase its distribution and production capacity as clinical development of its potential coronavirus vaccine nears conclusion. According to press reports Sino Biopharmaceutical, a Hong Kong-listed generics firm, acquired a 15% stake in a subsidiary of Sinovac. Sinovac has a coronavirus vaccine in late-stage development, which is undergoing large-scale …
Swiss biotech Noema has raised 54 million Swiss francs ($59m) to develop four neurological disorder drugs licensed in from Roche. The company is developing four phase 2 drugs brought in from Roche after the big Swiss pharma decided somebody else should take the risk of developing them. Roche, which decided the products were surplus to …
Olive AI, a startup automating routine administrative tasks for health systems, raised another $225 million in funding, bringing the total raised this year to $385 million.
The company, a facilitator of patient-clinician communication, plans to use the funds to bring new features and capabilities to market, as well as build strategic partnerships. It has also added Dr. Dana Gelb Safran as senior vice president of value-based care and population health.
A recent report by Rock Health found that Black and female founders of digital health companies received less funding and were more likely to bootstrap their companies than other groups.
Carbon Health, which more than tripled its footprint in the last year, plans to further grow its network of primary care and urgent care clinics with $100 million in new funding.
Lark Health, which offers AI-powered digital care platforms for chronic diseases, has raised $70 million in new funds, which it plans to use to expand its relationship with Anthem and eventually deepen partnerships with other payers and telehealth providers.
Gamified digital therapeutics firm Sidekick Health has raised $20 million in a Series A funding round, which it plans to use to develop its product offering. Based in Iceland, Sidekick said the oversubscribed funding round was led by Wellington Partners and Asabys Partners through its SAHII fund, with existing investors Novator and Frumtak Ventures. The …
Honor, a San Francisco-based startup that strikes partnerships with home care companies, raised $140 million in a series D round. The company helps manage back-office functions in exchange for a portion of their revenue.
French biotech SparingVision has raised 44.5 million euros ($52.7 million) to develop its gene therapy for a rare ocular disease. The round was led by 4BIO Capital and UPMC Enterprises with Jeito Capital and Ysios Capital joining. Current investors Bpifrance and Foundation Fighting Blindness also participated. In a statement, the company said funds will be …
Paige is a global digital pathology founded in 2017 by Thomas Fuchs, Dr. Sc., and colleagues from Memorial Sloan Kettering Cancer Center. The company involves computational pathology products that are targeted for patients and their care teams for effective, more informed treatment decisions. Paige has developed a platform to deliver novel technology to pathologists to …
Digital health companies once again set a record for funding in 2020, according to a report by Rock Health. They raised a total of $5.4 billion in the first half of the year.